AU8440975A - E. coli vaccine - Google Patents

E. coli vaccine

Info

Publication number
AU8440975A
AU8440975A AU84409/75A AU8440975A AU8440975A AU 8440975 A AU8440975 A AU 8440975A AU 84409/75 A AU84409/75 A AU 84409/75A AU 8440975 A AU8440975 A AU 8440975A AU 8440975 A AU8440975 A AU 8440975A
Authority
AU
Australia
Prior art keywords
coli vaccine
vaccine
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU84409/75A
Other languages
English (en)
Inventor
Michael R Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of AU8440975A publication Critical patent/AU8440975A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU84409/75A 1974-09-02 1975-08-29 E. coli vaccine Expired AU8440975A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Publications (1)

Publication Number Publication Date
AU8440975A true AU8440975A (en) 1977-03-03

Family

ID=10402419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84409/75A Expired AU8440975A (en) 1974-09-02 1975-08-29 E. coli vaccine

Country Status (9)

Country Link
JP (1) JPS5151514A (fr)
AU (1) AU8440975A (fr)
BE (1) BE832967A (fr)
DE (1) DE2538994A1 (fr)
DK (1) DK386875A (fr)
FR (1) FR2282908A1 (fr)
GB (1) GB1472624A (fr)
NL (1) NL7510120A (fr)
ZA (1) ZA755043B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
NZ199866A (en) * 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
CA1338705C (fr) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccins obtenus a partir de genes, antigenes de genes recombinants
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
NZ205392A (en) * 1982-09-02 1987-03-06 Unilever Plc Preparation of immunoglobulins against e.coli pili
IT1217303B (it) * 1984-02-01 1990-03-22 Enterovax Res Pty Ltd Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamenmto di malattie intestinali e simili e metodo di ingegneria gentica per la produzione dei detti vaccini
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE9100556D0 (sv) 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
ATE173166T1 (de) * 1992-09-04 1998-11-15 Univ Saskatchewan Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Also Published As

Publication number Publication date
BE832967A (fr) 1975-12-31
JPS5151514A (en) 1976-05-07
DE2538994A1 (de) 1976-06-16
FR2282908A1 (fr) 1976-03-26
FR2282908B1 (fr) 1978-11-10
NL7510120A (nl) 1976-03-04
ZA755043B (en) 1976-06-30
GB1472624A (en) 1977-05-04
DK386875A (da) 1976-03-03

Similar Documents

Publication Publication Date Title
NL7512365A (nl) Bevestiging.
CS351975A2 (en) Zpusob pripravy methyl-terc.butyletheru zpusob pripravy methyl terc.butyletheru
ZA751193B (en) 1,1-diaryl-1-oxadiazol-alkylamines
IL46736A (en) Substituted n-phenyl-2-trifluoro-methyl-4,6-dinitroanilines
NL7506101A (nl) Copolyamidepreparaten.
AU8440975A (en) E. coli vaccine
HK56980A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
AU7587674A (en) Infouenza vaccines
GB1401048A (en) Spiro-indan-1,3-pyrrolidines
IL48002A0 (en) 5-cyanoalkyl-1,3,4-thiadiazole-2-ylureas
ZA75954B (en) 1,2,4-triazolidin-3-ones
ZA756191B (en) 1,4-oxazepines
AU5949773A (en) Tge virus vaccine
JPS5128654A (en) Kotaidenkaikondensa no seizohoho
IL47487A0 (en) 9-thia-or oxothia-and dioxothia-11,12-seco-prostaglandins
AU7096274A (en) Vaccine
JPS5129165A (en) Tokei no jikokuhyojikiko
JPS5128113A (en) Konkuriitokan no seikeiyokatawaku
AU503647B2 (en) Antipregnancy vaccine
IE41250B1 (en) 2,2-bis-hydroxymethylalkanesulphonates
JPS5129771A (en) Setsusakuyu no bunrisochi
JPS5128992A (en) Nozurupuropera no kyabiteeshonyokuseisochi
JPS5127788A (en) Taiyodenchi no seizohoho
CA998474A (en) Modified bar code
IL46670A0 (en) 1,2,4-triazolidin-3-ones